EPS for InVivo Therapeutics Holdings Corp. (NVIV) Expected At $-0.13; Xilinx, Inc. (XLNX) Had 8 Bullish Analysts

April 17, 2018 - By Linda Rogers

Xilinx, Inc. (NASDAQ:XLNX) Logo

Analysts expect InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) to report $-0.13 EPS on May, 3.They anticipate $0.07 EPS change or 35.00% from last quarter’s $-0.2 EPS. After having $-0.13 EPS previously, InVivo Therapeutics Holdings Corp.’s analysts see 0.00% EPS growth. The stock increased 1.65% or $0.14 during the last trading session, reaching $8.45. About 14,245 shares traded. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) has declined 87.02% since April 17, 2017 and is downtrending. It has underperformed by 98.57% the S&P500.

Among 25 analysts covering Xilinx Inc. (NASDAQ:XLNX), 8 have Buy rating, 4 Sell and 13 Hold. Therefore 32% are positive. Xilinx Inc. had 70 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Xilinx, Inc. (NASDAQ:XLNX) has “Hold” rating given on Thursday, January 25 by Susquehanna. The stock has “Hold” rating by Deutsche Bank on Thursday, October 26. The rating was maintained by Barclays Capital with “Equal-Weight” on Thursday, October 26. The rating was maintained by KeyBanc Capital Markets with “Buy” on Wednesday, November 15. The rating was downgraded by Nomura to “Reduce” on Tuesday, January 3. The stock has “Hold” rating by Raymond James on Thursday, July 27. Barclays Capital maintained the stock with “Equal-Weight” rating in Thursday, July 27 report. The stock has “Buy” rating by KeyBanc Capital Markets on Wednesday, September 6. The firm has “Underweight” rating by Barclays Capital given on Wednesday, January 18. On Tuesday, July 18 the stock rating was upgraded by Barclays Capital to “Equal-Weight”. See Xilinx, Inc. (NASDAQ:XLNX) latest ratings:

06/04/2018 Broker: J.P. Morgan Rating: Sell New Target: $68.0000 Downgrade
06/04/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Underweight Old Target: $73 Downgrade
25/01/2018 Broker: Rosenblatt Rating: Hold Maintain
25/01/2018 Broker: Susquehanna Rating: Hold New Target: $70.0 Maintain
25/01/2018 Broker: Bank of America Old Rating: Underperform New Rating: Underperform Old Target: $61 New Target: $70 Maintain
25/01/2018 Broker: SunTrust Rating: Hold New Target: $79.0
25/01/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Neutral Old Target: $67 New Target: $73 Maintain
25/01/2018 Broker: Credit Suisse Rating: Buy New Target: $85.0 Maintain
25/01/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $66 New Target: $70 Maintain
24/01/2018 Broker: Jefferies Rating: Buy New Target: $85.0 Maintain

Xilinx, Inc. designs and develops programmable devices and associated technologies worldwide. The company has market cap of $17.83 billion. The Company’s programmable devices comprise integrated circuits in the form of programmable logic devices (PLDs), such as programmable system on chips, and three dimensional ICs; software design tools to program the PLDs; software development environments and embedded platforms; targeted reference designs; printed circuit boards; and intellectual property (IP). It has a 36.38 P/E ratio. The firm also offers development boards; development kits, including hardware, design tools, IP, and reference creates that are designed to streamline and accelerate the development of domain-specific and market-specific applications; and configuration products, such as one-time programmable and in-system programmable storage devices to configure field programmable gate arrays.

Investors sentiment increased to 1.21 in 2017 Q4. Its up 0.33, from 0.88 in 2017Q3. It is positive, as 43 investors sold Xilinx, Inc. shares while 169 reduced holdings. 76 funds opened positions while 181 raised stakes. 221.90 million shares or 4.44% less from 232.20 million shares in 2017Q3 were reported. Natixis invested in 22,914 shares. Texas-based Teacher Retirement Systems Of Texas has invested 0.03% in Xilinx, Inc. (NASDAQ:XLNX). 19,552 are held by Syntal Cap Limited Liability Company. Girard Prns holds 0.05% in Xilinx, Inc. (NASDAQ:XLNX) or 3,632 shares. First Personal Financial Ser reported 0% stake. California State Teachers Retirement Sys owns 417,703 shares or 0.06% of their US portfolio. Victory Cap Management Inc stated it has 0% in Xilinx, Inc. (NASDAQ:XLNX). 950 are owned by Smithfield Tru. Amundi Pioneer Asset Mgmt, a Massachusetts-based fund reported 467,503 shares. Bessemer Gp invested in 0% or 131 shares. Verition Fund Mgmt Ltd Liability accumulated 20,134 shares. The New York-based Millennium Mngmt has invested 0.09% in Xilinx, Inc. (NASDAQ:XLNX). Benjamin F Edwards And Inc holds 0.08% or 11,913 shares in its portfolio. Morgan Stanley invested in 5.14M shares or 0.09% of the stock. Us National Bank De has invested 0.02% in Xilinx, Inc. (NASDAQ:XLNX).

Since October 30, 2017, it had 0 insider buys, and 4 insider sales for $5.48 million activity. $308,396 worth of Xilinx, Inc. (NASDAQ:XLNX) shares were sold by Hover-Smoot Scott. 20,000 shares were sold by GAVRIELOV MOSHE, worth $1.52 million. Tong Vincent sold 19,687 shares worth $1.45 million.

The stock increased 2.61% or $1.78 during the last trading session, reaching $69.96. About 1.32 million shares traded. Xilinx, Inc. (NASDAQ:XLNX) has risen 23.85% since April 17, 2017 and is uptrending. It has outperformed by 12.30% the S&P500.

Xilinx, Inc. (NASDAQ:XLNX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: